GSE98009
Comparison of expression profiles of APP-depleted prostate cancer cells (LNCaP)
This analysis determines the relevanve of APP in prostate cancer as potential novel redox-regulator in androgen-responsive and castration-refractory prostate cancer Overall design: LNCaP cells either expressing empty vector (pcDNA3.1) or overexpressing wild-type androgenreceptor (AR) were stably transduced with shRNA against APP